# NU-SITE

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/nu-site-fpa>
- Manufacturer: [Medex, Inc.](https://devicerts.com/manufacturers/medex-inc) (United States, FDA 510(k) applicant)
- Device class: Class II (US FDA)
- FDA product code: FPA

## Overview

*AI-generated summary, 2026-09-25. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

NU-SITE is a device classified under product code FPA, which corresponds to a connector, intravenous. It received FDA 510(k) clearance K943897 on February 10, 1995, and was found substantially equivalent to a predicate device.

The device was manufactured by Medex, Inc. located in Hilliard, Ohio. It is supplied as a non-sterile, single-use or reusable connector for intravenous applications, with no MRI safety information provided in the data. Storage and handling should follow standard practices for medical devices of this type.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K943897 · decision 1995-02-10 · decision SESE · status: Active

## Recalls

- Z-0743-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0741-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0742-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0744-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0740-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0747-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.
- Z-0746-2024 · Class II · ongoing · initiated 2023-11-10 · matched through shared submission K943897, may concern other models: There is a manufacturing defect affecting specific rotator lots. Within this population, the inner diameter of the devices O-ring may be oversized affecting seal integrity. An inadequate seal may lead to a leak during infusion of medication which may potentially lead to under infusion of medication.

## Identifiers

- 510(k) Number: K943897 [FDA 510(k)]
- FDA product code: FPA [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 880.5440 [FDA 510(k)]
- Advisory committee: General Hospital [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: NU-SITE, Medex, Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/nu-site-fpa (data as of 2026-11-20).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-20
- JSON: <https://devicerts.com/devices/nu-site-fpa.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/nu-site-fpa
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
